Calcium resonium, which is used to treat hyperkalaemia over a short-term in chronic kidney disease, is associated with the development of which one of the following conditions?
Bowel Necrosis
Calcium resonium (a calcium/sodium polystyrene sulfonate cation-exchange resin) used for hyperkalaemia has been associated with intestinal/colonic necrosis, particularly when co-administered with sorbitol, making bowel necrosis a well-recognised serious adverse effect.
Sodium zirconium cyclosilicate and patiromer are commonly prescribed to chronic kidney disease patients because of their property of binding to which one of the following electrolytes?
Deficiency of which of the following mineral(s) can lead to hypocalcemia by impairing the ability of the parathyroid gland to secrete parathyroid hormone?
1. Phosphate
2. Magnesium
3. Sodium
4. Potassium
Select the correct answer using the code given below: